What is it about?
Atrial fibrillation (AF) detection in ischemic stroke patients triggers initiation of oral anticoagulant therapy (OAC). However, little is known regarding whether the persistency of AF affects long-term prognosis after ischemic stroke. We aimed to assess the impact of AF types and OAC on the outcome during a 10-year follow-up (FU) after first-ever ischemic stroke.
Featured Image
Why is it important?
All-cause mortality was independently associated with AF and was the greatest in stroke patients with permanent AF. Patients with recurrent AF receiving OAC have the most favorable outcome, similar to those without AF and significantly better than OAC-treated patients with permanent AF.
Perspectives
This finding supports the necessity of screening for paroxysmal atrial fibrillation in ischemic stroke survivors to start anticoagulant therapy.
Dr Maria A Baturova
Lunds Universitet
Read the Original
This page is a summary of: Non-permanent atrial fibrillation and oral anticoagulant therapy are related to survival during 10years after first-ever ischemic stroke, International Journal of Cardiology, April 2017, Elsevier,
DOI: 10.1016/j.ijcard.2017.01.040.
You can read the full text:
Contributors
The following have contributed to this page
